JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2012, Vol. 50 ›› Issue (6): 61-.

• Articles • Previous Articles     Next Articles

Smac mimic potentiates cisplatin-induced cell apoptosis of
ovarian cancer cells

QIAO Zhen1, LIU Pei-shu2, HAN Bing1, WANG Yu1   

  1. 1.  The medical school of Shandong University, Jinan 250012, China; 
    2. Department of obstetrics and gynecology of Qilu Hospital, Jinan 250012, China
  • Received:2011-11-16 Online:2012-06-10 Published:2012-06-10

Abstract:

Objective   To investigate the effect of a small Smac mimic molecule(compound 3) on cisplatin-induced cell apoptosis and growth inhibition of ovarian cancer cell lines. Methods   Cell viability and the growth inhibition ratio of the ovarian cancer cell lines SKOV3 were measured by MTT in the compound 3-treated group, the cisplatin-treated group and the combination treatment group. Apoptosis and protein expression were detected by flow cytometry and Western blot. Results   Cell viability was inhibited in the three groups, and it was time-dependent. The growth inhibition ratio of SKOV3 in the combination treatment group was more significantly increased than the cisplatintreated group, and the apoptotic rate of SKOV3 in the combination treatment group was more significantly increased than in the other groups. Expressions of XIAP in SKOV3 cells were decreased in the compound 3-treated group and the combination treatment group. Activated fragments of caspase 3 in the combination treatment group were more increased than in the other groups. Conclusion    Treatment with compound 3 enhances growth inhibition and apoptosis of SKOV3 induced by cisplatin. The proapoptotic effect of compound 3 was correlated with expression of XIAP.

Key words: Ovarian cancer; Smac mimic molecule; SKOV3 cell; Apoptosis; Cisplatin

CLC Number: 

  • R711.75
[1] LU Qun, SHEN Huan, WANG Cong, ZHENG Xing-bang, CHEN Xi, LIANG Rong, WEI Li-hui. Dehydroepiandrosterone supplementation improve in vitro fertilization outcome among women with poor response [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(2): 84-.
[2] WANG Yue-heng1, XING Yi2, WANG Jiu-ling1, DAI Jun3, LI Shu-ling1. Changes and significances of serum visfatin and TNF-α in
patients with polycystic ovary syndrome
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 94-.
[3] ZHAO Ying, YAN Lei, ZHANG Hui, YU Peng, LI Ming-jiang, ZHAO Xing-bo. Expression of SPAG9 in patients with serous epithelial ovarian tumors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 98-.
[4] DING Ping-ping, LI Qiang. Mechanisms involved in lysophosphatidic acid inducing  proliferation of ovarian carcinoma cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(7): 35-.
[5] SUN Ying, ZHENG Xiaojing, LI Mingjiang, ZHAO Xingbo. Effect of mifepristone on proliferation and expression of CEACAM6 of human ovarian cancer cell line SKOV3 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(5): 54-57.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!